Articles

Science & Innovation

Not Quite Out of the Woods: Risk for Lyme Disease Prevails in Suburban Environments

When many people think about places associated with tick exposure and risk for getting Lyme disease, they may picture a hike in the country or a camping trip in the woods. But encounters with infected ticks that can cause Lyme disease can happen doing routine activities around the yard, and common outdoor activities in your everyday life can put you at heightened risk for tick bites and, in turn, contracting Lyme disease.1Lyme disease is a bacterial infection transmitted to humans through a bite...

What is Non-Muscle Invasive Bladder Cancer?

According to recent research, bladder cancer is the 12th most common type of cancer worldwide.1 Of these cases, doctors stage (referring to the process of how far the cancer has progressed) about 75% as non-muscle invasive bladder cancer (NMIBC).1 Unlike other forms of bladder cancer, NMIBC only develops in cells that line the inside of the bladder, also known as urothelial or transitional cells.2 The bladder is made up of several layers, and in most cases, bladder cancer begins in the innermost...

April Social Media Round-Up—Trailblazer Cancer Research Grants, World Health Day, and More

April has come to a close and we are barreling towards the summer. Before you head outside to enjoy spring, take a moment to catch up with Pfizer’s social channels, which have been on fire.In April, Pfizer colleagues were honored in the list of 2026 Healthcare Businesswomen’s Association (HBA) Luminaries and Rising Stars, we recognized vaccines’ impact during World Immunization Week, and Pfizer scientists highlighted our research efforts.CEO Albert Bourla recognized Pfizer scientists who were...

Making Progress Against Cancer - From Cancer Research to Prevention and Screening

Advances in cancer care often begin with incremental steps in the lab that, over time, have the power to drive transformative breakthroughs. That’s why scientists are working around the clock to develop potential treatments that could help patients live longer, healthier lives. At Pfizer, Sharsti Sandall is one of those scientists.An executive director in Pfizer’s oncology research division, Sandall leads the antibody drug conjugate (ADC) group, which is a targeted treatment that delivers cancer...

How Biomarker Testing Helped a Lung Cancer Patient Get the Treatment She Needed

Earlier this month, Science Will Win, Pfizer’s award-winning podcast, wrapped up another successful season. Launched in February, season 6 included five episodes, each one focused on a different aspect of the fight against cancer, wrapping with last week’s season finale about AI’s impact on cancer care.All season long, each podcast episode has been accompanied by a full-length video conversation between host Dr. Raven Baxter – a molecular biologist and science educator – and one of her guests...

Science Will Win season finale explores AI in cancer care with Pfizer Chief Oncology Officer Jeff Legos

In February, Pfizer launched the sixth season of Science Will Win, our flagship podcast which recently reached 3 million downloads.The season finale focuses on the future of technology and artificial intelligence (AI) —and what they could mean for cancer research and care. Cancer research is moving faster than ever, but that progress is not always reflected in the patient experience. AI may be starting to change that. The last episode of Science Will Win Season 6 follows the human journey, from...

Science & Innovation

How AI Is Already Reshaping Cancer Care

When treating cancer, few things are more precious than time. Jeanine Bortel, Vice President and Head of AI Portfolio Development at Pfizer, who has developed clinical trials at Pfizer for more than two decades, remembers when she first witnessed the transformative potential of artificial intelligence (AI) put into practice to help address the needs of patients enrolled in cancer clinical trials.For years, Bortel’s work had run up against an inherent challenge: Many cancer patients miss out on...

Ever Wonder How Medicines Get Their Names?

Naming a medicine is more than just a creative exercise. It’s a critical, complicated, and collaborative step in bringing innovative treatments to patients.Some medicine names may sound unfamiliar, but there’s a lot of intention behind every syllable. Long before a treatment reaches patients, its name goes through a careful, highly regulated process designed to help prevent confusion and support safe use in real world healthcare settings.From early lab identifiers to globally recognized generic...

March Social Media Round-Up—2025 Annual Review, World’s Most Ethical Companies, and More

Spring has sprung! At Pfizer, we’re celebrating the changing seasons with exciting updates across our social channels.This March, we received another accolade (Ethisphere recognized Pfizer as one of the World’s Most Ethical Companies for the fifth year in a row), shared new episodes of “Science Will Win” and “What’s In My Lab”, and provided a behind-the-scenes look at our commitment to fighting cancer.We also published our 2025 Annual Review, with opening remarks from CEO Albert Bourla, while...

Science & Innovation

Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection

For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.1,2 Symptoms often resemble more common heart conditions, and early clues are easy to miss.1 But, new real-world evidence being shared at the American College of Cardiology (ACC) Scientific Sessions highlights opportunities to raise suspicion earlier in the diagnostic journey.“Many patients are already...

Science & Innovation

As Colorectal Cancer Rises in Younger Populations, Research and Education is More Important than Ever

At one time, colorectal cancer was a disease associated with older adults. Now, it’s considered the most deadly cancer in people younger than 50.1Even as deaths from the other most common cancers (breast cancer, lung cancer, brain cancer and leukemia) have fallen by 44% over a 30-year-period, according to the American Cancer Society, colorectal cancer deaths have increased 1.1% per year in younger people since 2005.1 It’s a development that’s alarming—and mystifying—healthcare providers and...

Pfizer Among World’s Most Ethical Companies for 5th Straight Year

Over the weekend, Hollywood celebrated itself at the Academy Awards. As the celebrities and craftspeople present would likely admit, they don’t do what they do to win prizes. Everyone likes a little recognition, but that’s not the driving force behind their work.The same holds true for Pfizer and its employees; we’re in this to make breakthroughs that change patients’ lives, not to take home trophies.That said, we are proud to share some news: for the fifth straight year, Pfizer has been...